COVID-19 47 Projects
55:58

Innate Immunity and Inflammasome activation in response to SARS-CoV-2

Global Immunotalks

1.2K views • 2 years ago

59:28

A humanized mouse model for COVID-19 - Infection and Pathogenesis

Global Immunotalks

1.1K views • 2 years ago

59:34

What is the value of community oximetry monitoring in people with SARS-CoV-2? – A prospective, open-label clinical study

Jane Wilcock

33 views • 2 years ago

1:00:12

Study title: Public Evaluation of Face Shield (Visor) Use whilst Shopping during the Coronavirus Pandemic 2: one patient test group and two friend test groups in England

Jane Wilcock

23 views • 2 years ago

1:04:30

COVID 19 - Framework for Remote Consultation

Jane Wilcock

26 views • 2 years ago

1:01:17

Assessing suppression strategies against epidemic outbreaks like COVID-19: the SPQEIR model

Christophe Ley

28 views • 2 years ago

39:30

Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19

Jian Zheng

1.4K views • 2 years ago

03:03

Sequence Analysis for SNP Detection and Phylogenetic Reconstruction of SARS-CoV-2 Isolated from Nigerian COVID-19 Cases

Idowu A. Taiwo

0 views • 1 year ago

02:22

Emergence of SARS-CoV-2 stains harbouring the signature mutations of both A2a and A3 clade

Rakesh Sarkar

0 views • 1 year ago

01:49

The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children

Asmaa Hachim

0 views • 1 year ago

01:48

Detection of autoimmune antibodies in severe but not in moderate or asymptomatic COVID-19 patients

Aisha D. Fakhro

0 views • 1 year ago

01:48

Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2

Eric James Nilles

0 views • 1 year ago

02:01

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2

Bianca A Trombetta

0 views • 1 year ago

00:49

Molecular Mechanism of Parosmia

Jane Parker

0 views • 1 year ago

01:40

An analysis of patients' perspectives on qualitative olfactory dysfunction using social media

Jane Parker

0 views • 1 year ago

01:27

Lockdown Effects on Sars-CoV-2 Transmission - The evidence from Northern Jutland

Kasper Planeta Kepp

0 views • 1 year ago

02:02

Factors associated with the spatial heterogeneity of COVID-19 in France: a nationwide ecological study

Jean Gaudart

0 views • 1 year ago

02:57

Postlockdown Dynamics of COVID-19 in New York, Florida, Arizona, and Wisconsin

Shery Scott

0 views • 1 year ago

01:55

COVID-19: Can early home treatment with Azithromycin alone or with Zinc help prevent hospitalisation, death, and long-COVID-19? A review

Philippe LEPERE

0 views • 1 year ago

01:23

Actionable druggable genome-wide Mendelian randomization identifies repurposingopportunities for COVID-19

Liam Gaziano

0 views • 1 year ago

02:15

Artificial Intelligence Applications for COVID-19 in Intensive Care and Emergency Settings: A Systematic Review

Marcel Lucas Chee

0 views • 1 year ago

01:45

Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays

Andrea N Loes

0 views • 1 year ago

01:46

Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail

Jinhui Dong

0 views • 1 year ago

04:01

Seroprevalence of SARS-CoV-2 during pregnancy and associated outcomes: results from an ongoing prospective cohort study, New York City

Nina M Molenaar

0 views • 1 year ago

01:10

Neutralizing Antibody Responses in COVID-19 Convalescent Sera

William T Lee

0 views • 1 year ago

01:41

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

Tongqing Zhou

0 views • 1 year ago

01:19

Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV-2 Replication in Cell Culture

Khushboo Bafna

0 views • 1 year ago

02:29

Stages of COVID-19 pandemic and paths to herd immunity by vaccination: dynamical model comparing Austria, Luxembourg and Sweden

Francoise Kemp

0 views • 1 year ago

01:25

Dynamical SPQEIR model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks

Daniele Proverbio

0 views • 1 year ago

01:20

Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals

Elaine C Chen

0 views • 1 year ago

02:08

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

Seth J. Zost

0 views • 1 year ago

02:19

High SARS-CoV-2 seroprevalence in Health Care Workers but relatively low numbers of deaths in urban Malawi

Marah Grace Chibwana

0 views • 1 year ago

01:34

The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication

Iart Luca Shytaj

0 views • 1 year ago

01:24

SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB

Christopher J. Neufeldt

0 views • 1 year ago

01:03

ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2

Leon Tribolet

0 views • 1 year ago

01:36

COVID-19 and Cholinergic Anti-inflammatory Pathway: In silico Identification of an Interaction between alpha7 Nicotinic Acetylcholine Receptor and the Cryptic Epitopes of SARS-CoV and SARS-CoV-2 Spike Glycoproteins

George Lagoumintzis

0 views • 1 year ago

01:46

Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2

Yuan-Lin Kang

0 views • 1 year ago

02:07

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

Sai Priya Anand

0 views • 1 year ago

02:02

A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses

Alexandra Tauzin

0 views • 1 year ago

01:34

Decline of humoral responses against SARS-CoV-2 Spike in convalescent individuals

Guillaume Beaudoin-Bussières

0 views • 1 year ago

01:34

Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike

Jérémie Prévost

0 views • 1 year ago

01:17

Live imaging of SARS-CoV-2 infection in mice reveals neutralizing antibodies require Fc function for optimal efficacy

Irfan Ullah

0 views • 1 year ago

01:45

Antibody binding to SARS-CoV-2 S glycoprotein correlates with, but does not predict neutralization

Shilei Ding

0 views • 1 year ago

02:57

Renin-angiotensin system blockers and mortality in COVID-19: a territory-wide study from Hong Kong

Jiandong Zhou

0 views • 1 year ago

00:24

Insights into the molecular mechanism of anticancer drug ruxolitinib repurposable in COVID-19 therapy

Manisha Mandal

0 views • 1 year ago

00:45

Phasic containment of COVID-19 in substantially affected states of India

Manisha Mandal

0 views • 1 year ago

01:18

Detection of transmission change points during unlock-3 and unlock-4 measures controlling COVID-19 in India

Manisha Mandal

0 views • 1 year ago